Department of Paediatric Nephrology, Royal Manchester Children's Hospital, Oxford Road, Manchester, M13 9WL, UK.
Wellcome Centre for Cell-Matrix Research, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Pediatr Nephrol. 2020 Dec;35(12):2373-2376. doi: 10.1007/s00467-020-04738-6. Epub 2020 Sep 3.
Hypertension is a common problem in stage 5 chronic kidney disease (CKD 5) and following kidney transplantation (KT). There is limited data on the outcome of children with CKD 5 who undergo bilateral native nephrectomies (BNN) for the management of hypertension.
Retrospective review of 134 children who underwent KT at a single centre over a 10-year period and had a minimum follow up period of 1 year. Children who had undergone BNN for hypertension prior to, and after, KT were identified and their outcome with regard to blood pressure (BP), anti-hypertensive medications and graft function was compared with that of the rest of the cohort.
Eleven children (8.2%) underwent BNN, including 2 performed after KT, due to poorly controlled BP despite a median of 3 anti-hypertensive medications. The median age at BNN was 7 years (range 0.5-17 years). All 9 children who underwent BNN prior to KT discontinued anti-hypertensive medication after a median of 6 months and remained normotensive post KT. After a median follow up of 5 years following KT, there was a trend towards lower prevalence of hypertension in children who underwent BNN compared with that of the rest of the cohort (9.1% vs 25%, p 0.23). None of the children who underwent BNN had any evidence of proteinuria, and the median eGFR was 74 ml/min/1.73 m 2 after KT.
BNN for severe hypertension in CKD 5 is associated with resolution of hypertension prior to KT. It is also associated with a trend towards lower prevalence of hypertension and good graft function following KT.
高血压是 5 期慢性肾脏病(CKD5)和肾移植(KT)后的常见问题。对于接受双侧原肾切除术(BNN)治疗高血压的 CKD5 儿童的结局,数据有限。
回顾性分析了在单中心接受 KT 的 134 例儿童,其随访时间至少为 1 年。确定了在 KT 前和 KT 后因高血压接受 BNN 的儿童,并比较了他们的血压(BP)、抗高血压药物和移植物功能的结果与队列中其余儿童的结果。
11 例儿童(8.2%)接受了 BNN,包括 2 例在 KT 后进行,原因是尽管中位数使用了 3 种抗高血压药物,但 BP 仍控制不佳。BNN 的中位年龄为 7 岁(范围 0.5-17 岁)。所有在 KT 前接受 BNN 的 9 例儿童在中位 6 个月后停止使用抗高血压药物,并且在 KT 后血压正常。在 KT 后中位随访 5 年后,与其余队列相比,接受 BNN 的儿童高血压的患病率呈下降趋势(9.1% vs 25%,p=0.23)。接受 BNN 的儿童均无蛋白尿证据,并且 KT 后 eGFR 的中位数为 74ml/min/1.73m2。
在 CKD5 中,严重高血压的 BNN 与 KT 前高血压的缓解相关。它也与 KT 后高血压的患病率较低和移植物功能良好的趋势相关。